82 filings
Page 2 of 5
8-K
4b291vtgy 13
2 Mar 20
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides
8:13am
425
n65dutg1nk jf
23 Jan 20
Business combination disclosure
4:03pm
425
6j63d qeqwinwrer
16 Jan 20
Business combination disclosure
5:22pm
425
0ofqfpnl torwk8ns5
16 Jan 20
Business combination disclosure
3:55pm
425
eubi02um3ed92jvm8cyh
16 Jan 20
Business combination disclosure
3:53pm
425
1x3bd61o6ii 9l6b
16 Jan 20
Business combination disclosure
3:52pm
8-K
5bt6l
16 Jan 20
Form of Voting Agreement
9:34am
425
rxbrr9fp
16 Jan 20
Business combination disclosure
9:34am
425
tvspuylrkyho
16 Jan 20
Business combination disclosure
8:51am
8-K
g46v 1fa1sus
20 Nov 19
Neon Therapeutics Reports Announces New Strategic Focus on Novel T Cell Programs
4:14pm
8-K
me4y4kw3oed1
12 Nov 19
Neon Therapeutics Reports Third Quarter 2019 Financial Results
9:00am
8-K
2vbg ze4wqhhr3b
8 Nov 19
Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
8:56am
8-K
o5kxh2o024h97j
6 Aug 19
Neon Therapeutics Reports Second Quarter 2019 Financial Results
8:14am
8-K
slf etpr7
15 Jul 19
Other Events
7:47am
EFFECT
zzm4qgzjx
9 Jul 19
Notice of effectiveness
12:15am
UPLOAD
c1kwth4nc3 uj31k6
8 Jul 19
Letter from SEC
12:00am
CORRESP
crje1frmhtuq 9rxex
3 Jul 19
Correspondence with SEC
12:00am
S-3
7h3ntjro2o6rv e8
1 Jul 19
Shelf registration
4:22pm